{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:12:53Z","timestamp":1788671573779,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI145925"],"award-info":[{"award-number":["R01AI145925"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000275","name":"The Leverhulme Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcf.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:50:43Z","timestamp":1788551443000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbial content versus microbial interaction: the impact of medications on CF airway microbial ecosystems"],"prefix":"10.1016","author":[{"given":"Pok-Man","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahan Rudland","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Askenasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.08.011_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ije\/dyx196","article-title":"Data resource profile: the UK Cystic Fibrosis Registry","volume":"47","author":"Taylor-Robinson","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0002","series-title":"UK cystic fibrosis registry 2023 annual data report","author":"Naito","year":"2024"},{"key":"10.1016\/j.jcf.2026.08.011_bib0003","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41396-022-01218-7","article-title":"Decreased efficacy of antimicrobial agents in a polymicrobial environment","volume":"16","author":"O\u2019Brien","year":"2022","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2026.08.011_bib0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/pathogens10020144","article-title":"Clinical implications of polymicrobial synergism effects on antimicrobial susceptibility","volume":"10","author":"Little","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jcf.2026.08.011_bib0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcf.2019.01.008","article-title":"Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review","volume":"18","author":"Somayaji","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.011_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00311-21","article-title":"The gut-lung axis in Cystic fibrosis","volume":"203","author":"Price","year":"2021","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung axis in health and Respiratory diseases: a place for inter-organ and inter-Kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jcpt.12783","article-title":"Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation","volume":"44","author":"Tran","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jcf.2026.08.011_bib0009","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1165\/rcmb.2012-0059PS","article-title":"Cystic Fibrosis Therapy: a Community Ecology perspective","volume":"48","author":"Conrad","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/rccm.201312-2129PP","article-title":"The upper Respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography","volume":"189","author":"Whiteson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.08.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02284-14","article-title":"Application of a neutral community model to assess structuring of the Human lung microbiome","volume":"6","author":"Venkataraman","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.jcf.2026.08.011_bib0012","article-title":"Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients","volume":"97","author":"Huang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jcf.2026.08.011_bib0013","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1038\/s41467-024-49150-y","article-title":"Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis","volume":"15","author":"Widder","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.08.011_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41522-016-0002-1","article-title":"Ecological networking of cystic fibrosis lung infections","volume":"2","author":"Quinn","year":"2016","journal-title":"Npj Biofilms Microb"},{"key":"10.1016\/j.jcf.2026.08.011_bib0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/antibiotics14111061","article-title":"Long-term macrolides in chronic Respiratory diseases: dusk or a new dawn? A narrative review","volume":"14","author":"Previtero","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.jcf.2026.08.011_bib0016","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/medicina61091605","article-title":"Airway microbiome in children with Cystic Fibrosis: a review of microbial shifts and therapeutic impacts","volume":"61","author":"Buruian\u0103","year":"2025","journal-title":"Medicina (Mex)"},{"key":"10.1016\/j.jcf.2026.08.011_bib0017","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/antibiotics10070827","article-title":"Polymicrobial interactions in the Cystic Fibrosis airway microbiome impact the antimicrobial susceptibility of Pseudomonas aeruginosa","volume":"10","author":"Reece","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jcf.2026.08.011_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.02146","article-title":"Insights into cystic fibrosis polymicrobial consortia: the role of species interactions in biofilm development, phenotype, and response to In-use antibiotics","volume":"7","author":"Magalh\u00e3es","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0019","article-title":"In vitro recapitulation of the polymicrobial communities associated with cystic fibrosis airway infections","author":"O\u2019Brien","year":"2021","journal-title":"Apollo - Univ. Camb. Repos."},{"key":"10.1016\/j.jcf.2026.08.011_bib0020","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1099\/mic.0.000352","article-title":"An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms","volume":"162","author":"Harrison","year":"2016","journal-title":"Microbiology"},{"key":"10.1016\/j.jcf.2026.08.011_bib0021","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81604","article-title":"Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system","volume":"12","author":"Jean-Pierre","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jcf.2026.08.011_bib0022","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41396-022-01252-5","article-title":"Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection","volume":"16","author":"Ghuneim","year":"2022","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2026.08.011_bib0023","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12968\/jowc.2011.20.5.232","article-title":"Molecular diagnostics and personalised medicine in wound care: assessment of outcomes","volume":"20","author":"Dowd","year":"2011","journal-title":"J Wound Care"},{"key":"10.1016\/j.jcf.2026.08.011_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1178131","article-title":"Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota","volume":"14","author":"Ho","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00292-20","article-title":"High-resolution longitudinal dynamics of the cystic fibrosis sputum microbiome and metabolome through antibiotic therapy","volume":"5","author":"Raghuvanshi","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.jcf.2026.08.011_bib0026","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41592-018-0141-9","article-title":"Qiita: rapid, web-enabled microbiome meta-analysis","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcf.2026.08.011_bib0027","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ismej.2011.139","article-title":"An improved greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea","volume":"6","author":"McDonald","year":"2012","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2026.08.011_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2307\/1358","article-title":"The ten-year cycle in numbers of the Lynx in Canada","volume":"11","author":"Elton","year":"1942","journal-title":"J Anim Ecol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0029","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcf.2026.08.011_bib0030","series-title":"2024 Patient registry annual data report","year":"2024"},{"key":"10.1016\/j.jcf.2026.08.011_bib0031","series-title":"Australian cystic fibrosis data registry 2023 annual report","author":"Ahern","year":"2024"},{"key":"10.1016\/j.jcf.2026.08.011_bib0032","doi-asserted-by":"crossref","first-page":"17651","DOI":"10.1002\/ece3.8453","article-title":"Ecological theory of mutualism: robust patterns of stability and thresholds in two-species population models","volume":"11","author":"Hale","year":"2021","journal-title":"Ecol Evol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0033","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00594-16","article-title":"rRNA binding sites and the molecular mechanism of action of the tetracyclines","volume":"60","author":"Chukwudi","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2026.08.011_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-198223060-00001","article-title":"Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections","volume":"23","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.jcf.2026.08.011_bib0035","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.39221","article-title":"Corticosteroid-induced psychosis: a report of three cases","author":"Bachu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2026.08.011_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00441","article-title":"In vitro interactions of Pseudomonas aeruginosa with scedosporium species frequently associated with cystic fibrosis","volume":"10","author":"Homa","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0037","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1469-0691.2010.03189.x","article-title":"The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples","volume":"16","author":"Rogers","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcf.2026.08.011_bib0038","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.diagmicrobio.2008.06.011","article-title":"Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections","volume":"62","author":"Rogers","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jcf.2026.08.011_bib0039","article-title":"Benzalkonium chlorides: uses, regulatory status, and microbial resistance","volume":"85","author":"Pereira","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0040","series-title":"Antiseptic steward","first-page":"407","article-title":"Benzalkonium chloride","author":"Kampf","year":"2024"},{"key":"10.1016\/j.jcf.2026.08.011_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1511229","article-title":"Gut microbiota trigger host liver immune responses that affect drug-metabolising enzymes","volume":"15","author":"Rao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0042","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-020-18871-1","article-title":"Health and disease markers correlate with gut microbiome composition across thousands of people","volume":"11","author":"Manor","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.08.011_bib0043","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jcf.2026.08.011_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.659918","article-title":"Phylogeny- and abundance-based metrics allow for the consistent comparison of core gut microbiome diversity indices across host species","volume":"12","author":"Risely","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2026.08.011_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.fbr.2014.10.002","article-title":"Candida albicans: molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus","volume":"28","author":"Lindsay","year":"2014","journal-title":"Fungal Biol Rev"},{"key":"10.1016\/j.jcf.2026.08.011_bib0046","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/nu14183717","article-title":"\u03b1-tocopherol pharmacokinetics in adults with cystic fibrosis: benefits of supplemental vitamin C administration","volume":"14","author":"Traber","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.08.011_bib0047","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/thoraxjnl-2019-214187","article-title":"Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome","volume":"75","author":"Nelson","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2026.08.011_bib0048","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91082.3","article-title":"Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis","volume":"12","author":"Kade\u0159\u00e1bkov\u00e1","year":"2026","journal-title":"eLife"},{"key":"10.1016\/j.jcf.2026.08.011_bib0049","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.3390\/ijms23073513","article-title":"The effect of CFTR modulators on airway infection in cystic fibrosis","volume":"23","author":"Harvey","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932603732X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932603732X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:23:02Z","timestamp":1788668582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932603732X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S156919932603732X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial content versus microbial interaction: the impact of medications on CF airway microbial ecosystems","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}